Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F8DUC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,117
Award facts
- Contract value 100% obligated
- $13,116.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,116.84 to Amerisourcebergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) with an ultimate completion date of January 28, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is being performed in Conshohocken, Pennsylvania. The award was issued on January 27, 2026, and represents a task order under Amerisourcebergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion contract vehicle through December 2026 that provides comprehensive global pharmaceutical support to military healthcare programs worldwide.
Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the Amerisourcebergen brand), is a major pharmaceutical distributor and critical federal vendor specializing in medical procurement for military and veteran healthcare systems. The company maintains extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, branded and generic drugs, vaccines, and medical supplies. This delivery order for RINVOQ ER—a JAK inhibitor used in rheumatoid arthritis treatment—reflects the company's demonstrated capability to supply essential prescription medications to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its flexible and comprehensive contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F8DUC?
SPE2DR26F8DUC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F8DUC worth?
The government has obligated $13,117 on SPE2DR26F8DUC.
Is contract SPE2DR26F8DUC an order under another contract?
Yes. SPE2DR26F8DUC is a delivery order under SPE2DR25D7058, an indefinite delivery contract.
Was contract SPE2DR26F8DUC competed?
The extent of competition for SPE2DR26F8DUC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award